retatrutide safety profile clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— glp-1 medications nutrient deficiency skin barrier Size:Small ~6 cm

retatrutide safety profile clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— glp-1 medications nutrient deficiency skin barrier Size:Small ~6 cm

glp-1 medications nutrient deficiency effects Nutritional priorities to support therapy for obesity: a joint Advisory

While there is no evidence that GLP-1 medications stimulate testosterone production directly, the increase in testosterone driven by their weight-loss effects appears comparable to that of other weight loss strategies

skin barrier

Size:Small ~6 cm

In patients with active or poorly controlled disease, GLP-1 medications can theoretically worsen gastrointestinal symptoms through their effect on stomach emptying and gut motility